Evidence map›Paper›PMID 39436410›Full record

ArticlePflugers Archiv : European journal of physiology2025

TRPC3-mediated NFATc1 calcium signaling promotes triple negative breast cancer migration through regulating glypican-6 and focal adhesion.

Yan Wang, Xiaosheng Zhuang, Yanxiang Qi, Lung Yiu, Zhenping Li, Yuk Wah Chan, Xianji Liu, Suk Ying Tsang

Abstract read
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Multi-omic Profiling of Recurrence Risk Across Breast Cancer Subtypes.medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yan Wang *School of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Xiaosheng Zhuang *School of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Yanxiang QiSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Lung YiuSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Zhenping LiSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Yuk Wah ChanSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Xianji LiuSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Suk Ying TsangSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China. fayetsang@cuhk.edu.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canonical transient receptor potential isoform 3 (TRPC3), a calcium-permeable non-selective cation channel, has been reported to be upregulated in breast cancers and a modulator of cell migration. Calcium-sensitive transcription factor NFATc1, which is important for cell migration, was shown to be frequently activated in triple negative breast cancer (TNBC) biopsy tissues. However, whether TRPC3-mediated calcium influx would activate NFATc1 and affect the migration of TNBC cells, and, if yes, the underlying mechanisms involved, remain to be investigated. By immunostaining followed by confocal microscopy, TNBC lines MDA-MB-231 and BT-549 were both found to express TRPC3 on their plasma membrane while ER

Indexed as

Calcium SignalingCell MovementFocal AdhesionsNFATC Transcription FactorsTriple Negative Breast NeoplasmsTRPC Cation ChannelsCell Line, TumorFemaleHumansNFATC1 protein, humanNFATC3 protein, humanNFATC Transcription FactorsTRPC3 cation channelTRPC Cation ChannelsCell migrationFocal adhesionsGlypican 6NFATc1Triple-negative breast cancerTRPC3

Identifiers

PMID39436410
PMCPMC11762004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.